ArticleJournal of musculoskeletal & neuronal interactions2026
Astragalus Polysaccharides Attenuate LPS-Induced Degenerative Responses in Primary Rat Chondrocytes linked to the NLRP3/CASPASE-1 Axis.
Article in Journal of musculoskeletal & neuronal interactions, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesCartilage degeneration is a key pathological change in osteoarthritis (OA). This study investigated the mechanism by which Astragalus polysaccharides (APS) alleviate cartilage degeneration.
methodsPrimary rat articular chondrocytes were isolated, and a cell degeneration model was induced with lipopolysaccharide (LPS). Different concentrations of APS (100, 200, 400 mg/L) were tested, and NLR family pyrin domain containing 3 (NLRP3)-knockdown chondrocytes were generated. Cell viability (CCK-8 metabolic activity), levels of inflammatory factors, and gene and protein levels of markers associated with cartilage degeneration (including Acan, Adamts5, Nlrp3, and Caspase-1) were measured.
resultsAPS at different concentrations improved cell viability (CCK-8) of LPS-induced chondrocytes, inhibited the inflammatory cytokines interleukin-1β (IL-1β) and IL-18, upregulated Acan, and downregulated Adamts5, Nlrp3, and Caspase-1. Nlrp3 knockdown produced similar effects to APS, improving chondrocyte degeneration in vitro.
conclusionAPS alleviates LPS-induced degenerative responses in primary rat chondrocytes, and its protective effect is associated with modulation of the NLRP3/CASPASE-1 axis.
Indexed as
Identifiers
42220035PMC13223790What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.